Annals of the Rheumatic Diseases, 0003-4967

Journal

141 - 150 out of 159Page size: 10

Publications

  1. 2018
  2. Published

    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

    Karim Raza, 12 Mar 2018, In: Annals of the Rheumatic Diseases. 77, p. 476-479

    Research output: Contribution to journal › Article › peer-review

  3. E-pub ahead of print

    Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?

    Benjamin Fisher & Simon Bowman, 13 Apr 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  4. E-pub ahead of print

    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis

    Adam Croft, Christopher Buckley, 30 Jul 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  5. E-pub ahead of print

    Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

    Jennifer Marshall, Ilfita Sahbudin, Karim Raza, Andrew Filer, Christopher Buckley, 14 Dec 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multinational SLE inception cohort

    Caroline Gordon, 20 Dec 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  7. 2019
  8. Published

    Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome

    Saba Nayar, Joana Campos, David Gardner, Christopher Buckley, Simon Bowman, Benjamin Fisher & Francesca Barone, 10 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 249-260 12 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data

    Anuradhaa Subramanian, Nicola Adderley, Lorraine Harper & Krishnarajah Nirantharakumar, Feb 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 261-269 9 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

    Lorraine Harper, Mar 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 399-405

    Research output: Contribution to journal › Article › peer-review

  12. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journal › Review article › peer-review

Previous 1...11 12 13 14 15 16 Next